Search results
Jerry McMahon, PhD Chief Executive Officer & President Jerry has over 30 years of biotechnology leadership, scientific innovation, creative deal-making, and financing experience.
7 Sep 2022 · 7 September 2022, Cambridge, UK: STORM Therapeutics Ltd. (STORM), the biotechnology company discovering and developing novel small molecule therapies targeting RNA modification enzymes for oncology and other diseases, today announced the appointment of Dr. Gerald (Jerry) McMahon as President and Chief Executive Officer and Board Director.
View Jerry McMahon’s profile on LinkedIn, a professional community of 1 billion members. Dr. McMahon brings more than 30 years of exceptional biotechnology leadership, scientific…
7 Sep 2022 · STORM Therapeutics Appoints Dr. Jerry McMahon as Chief Executive Officer. Sep 07, 2022, 03:00 ET. Share this article. Industry veteran to lead STORM as it transitions into a clinical-stage...
Jerry McMahon has over 30 years of biotechnology leadership, scientific innovation, deal-making, and financing experience. With broad disease-area expertise and a specialty in oncology therapeutics, he has held scientific, pharmaceutical, and venture capital positions, as well as CEO or president positions in multiple biotechnology companies, ...
Jerry McMahon is President/CEO at Storm Therapeutics Ltd. See Jerry McMahon's compensation, career history, education, & memberships.
Dr Jerry McMahon has been appointed CEO for STORM Therapeutics as it transitions into a clinical-stage company with a pipeline of products targeting RNA modifying enzymes.
